ANTIIDIOTYPES AGAINST ANTIPHOSPHOLIPID ANTIBODIES ARE PRESENT IN NORMAL POLYSPECIFIC IMMUNOGLOBULINS FOR THERAPEUTIC USE

被引:50
作者
CACCAVO, D
VACCARO, F
FERRI, GM
AMOROSO, A
BONOMO, L
机构
[1] Clinica Medica III, University 'La Sapienza', Rome
关键词
D O I
10.1006/jaut.1994.1039
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study we found that antiphospholipid activity in sera from patients with anticardiolipin antibodies was inhibited in vitro by therapeutic polyspecific normal immunoglobulins (IVIg). In fact, F(ab'), fragments from IVIg (IVIg-F(ab')2) inhibited the binding of anticardiolipin antibodies to the corresponding antigen in a dose-dependent fashion, thus suggesting that the interaction between IVIg-F(ab'), and anticardiolipin antibodies occurred within or near the antigen combining site. The maximal inhibition ranged from 35.25 +/- 5.56 to 64 +/- 5.48%. In addition, patients' IgG containing antiphospholipid activity specifically bound insolubilized IVIg-F(ab')2, as assessed by enzyme-linked immunosorbent assay (ELISA). These results indicate that IVIg obtained from a large pool of normal donors contain anti-idiotypic antibodies directed against idiotypes located on antiphospholipid antibodies. Moreover, our observations suggest that the reported favourable effect of high dose infusion of IVIg in patients with recurrent abortions due to antiphospholipid antibodies may depend, at least in part on inhibition of the binding of such autoantibodies to the corresponding antigens (s) and/or inactivation of idiotype bearing B cell clones.
引用
收藏
页码:537 / 548
页数:12
相关论文
共 27 条
[1]  
ABDOU NI, 1980, J CLIN INVEST, V67, P1297
[2]  
BALLOW M, 1991, CANCER, V68, P1430, DOI 10.1002/1097-0142(19910915)68:6+<1430::AID-CNCR2820681405>3.0.CO
[3]  
2-4
[4]  
BERCHTOLD P, 1989, BLOOD, V74, P2414
[5]  
BONA C, 1984, RECEPTOR BIOCH METHO, V4, P141
[6]  
CARRERAS LO, 1988, LANCET, V2, P393
[7]   INVITRO PRODUCTION OF AN ANTI-DNA IDIOTYPE BY LYMPHOCYTES OF NORMAL SUBJECTS AND PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
DATTA, SK ;
NAPARSTEK, Y ;
SCHWARTZ, RS .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 38 (03) :302-318
[8]   NORMAL IMMUNOGLOBULIN-G (IGG) FOR THERAPEUTIC USE (INTRAVENOUS IG) CONTAIN ANTIIDIOTYPIC SPECIFICITIES AGAINST AN IMMUNODOMINANT, DISEASE-ASSOCIATED, CROSS-REACTIVE IDIOTYPE OF HUMAN ANTI THYROGLOBULIN AUTOANTIBODIES [J].
DIETRICH, G ;
KAZATCHKINE, MD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :620-625
[9]   NATURALLY-OCCURRING ANTI-IDIOTYPIC ANTIBODIES IN MYASTHENIA-GRAVIS PATIENTS [J].
DWYER, DS ;
BRADLEY, RJ ;
URQUHART, CK ;
KEARNEY, JF .
NATURE, 1983, 301 (5901) :611-614
[10]  
HUGHES GRV, 1986, J RHEUMATOL, V13, P486